Apollomics Inc Ordinary Shares - Class A APLM 深 沪
已收盘 10-10 16:00:00 美东时间
18.4331
0.000
0.00%
华盛通- 最 高20.98
- 今 开12.60
- 成交量 0股
- 最 低 12.16
- 昨 收 18.4331
- 总市值 2033.72万
- 52周最高 35.98
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 3.659
- 委 比 0.00%
- 总股本 110.33万
- 历史最高 4900.00
- 量 比 0
- 振 幅 47.85%
- 历史最低 3.659
- 每 手 1
- 风险率 3.65%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Nasdaq Halts Apollomics Inc., Ltd.
The Nasdaq Stock Market announced on September 17, 2025 that trading in Apollomics Inc., Ltd. was halted at 14:37:17 Eastern Time for additional information requested from the company. The last sale price of the company’s ordinary shares was $18.4331 (Nasdaq: APLM), and warrants was $0.0191 (Nasdaq: APLMW). Trading will remain halted until Apollomics Inc. fully satisfies Nasdaq’s request.
09-17 21:48
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Biodesix (NASDAQ:BDSX) shares increased by 21.6% to $0.52 during Wedne...
09-04 05:06
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Ironwood Pharmaceuticals (NASDAQ:IRWD) stock rose 15.2% to $0.71 durin...
06-14 05:05
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Biodesix (NASDAQ:BDSX) shares increased by 72.6% to $0.47 during Wedne...
05-22 01:06
Apollomics shares are trading lower. The company reported FY24 financial results.
Apollomics shares are trading lower. The company reported FY24 financial result...
04-05 02:48
Apollomics, LaunXP enter development, commercial agreement for Vebreltinib
Apollomics (NASDAQ:APLM) and LaunXP International, an affiliate of LaunXP Biomedical, announced that the parties have entered into an agreement for the development and commercialization in Asia of veb...
03-31 21:20
(APLM) - Analyzing Apollomics's Short Interest
Apollomics's (NYSE:APLM) short percent of float has risen 16605.56% since its l...
2024-12-04 00:15
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) stock moved upwards by 26.4% to $...
2024-11-20 05:06
Apollomics stock rallies 30% on Phase 2 vebreltinib data
Apollomics (NASDAQ:APLM) stock rallied 30% in morning trading Tuesday after the company announced positive Phase 2 data for its oncology drug candidate vebreltinib. The preliminary data showed a 43% o...
2024-08-13 22:49
惠誉常青：就中国交通建设(01800.HK)的绿色融资框架出具第二方意见
本文来自微信公众号“惠誉评级”，作者周汉威、何心怡。 7月30日，惠誉常青已就中国交通建设股份有限公司(中国交建)的绿色融资框架出具第二方意见。在该框架下，中国...
2024-07-30 17:24
